“MASLD and T2DM represent intersecting global epidemics with substantial clinical and public health implications,” wrote the ...
Tandem Diabetes Care, Inc.’s TNDM flagship offering, t:slim X2 insulin pump, has recently become the first automated insulin delivery (AID) system to be integrated with Abbott’s ABT latest innovation ...
Senseonics rolls out Eversense 365 integrated with Sequel's twiist AID system, aiming to boost CGM adoption with its ...
TOKYO and COLUMBIA, Md., March 28, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that it has entered into an agreement ...
Collaborative, interdisciplinary care, a strategy that relies on multiple specialties working together to coordinate a treatment plan, plays an integral role in disease prevention. This approach is ...
The Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA) program is an innovative, patient-centered system of care developed by the University Hospitals Harrington Heart ...
One in four middle-aged adults who survive to age 85 will develop heart failure, according to current estimates. Intervention programs to improve lifestyles are widely advocated, but do they actually ...
Tandem Diabetes Care, Inc. TNDM recently launched the updated t:slim X2 insulin pump software with Dexcom G7 Continuous Glucose Monitoring (“CGM”) integration in the United States. This marks the ...
Please provide your email address to receive an email when new articles are posted on . In the past 5 years, what change has had the greatest impact on HbA1c in diabetes care? Is it continuous glucose ...
People with diabetes and advanced chronic kidney disease (CKD) benefited from the availability of diabetes expertise in a new model of integrated care for both conditions. The care model, led by a ...
Dietary advice and structured lifestyle interventions remain central to the effective management of Type 2 diabetes, with ...
The World Health Organization recognizes that diabetes is a global epidemic with approximately 6% of the world’s population (420 million+ people) living with either Type 1 or Type 2 diabetes. This ...